日本婦人科腫瘍学会「Endometrial cancer」ページです。婦人科腫瘍学に関する情報を市民の皆さまへ提供しています。本会は学術団体として婦人科腫瘍学の進歩・発展をはかると同時に、会員以外の一般の方にも婦人科腫瘍に関する情報を提供し、広く社会に貢献することを目指しています。 子宮內膜癌（英語： endometrial cancer ）是原發於子宮內膜的一組上皮性惡性腫瘤，以來源於子宮內膜腺體的腺癌最為常見 [1] 。 其病因是由於細胞異常的生長，並且具備了能夠侵襲或擴散到身體其他部位的能力 [8] 。 最常見的初始症狀為非經期陰道出血 [1] 。 其他可能出現的症狀包括 解尿疼痛 Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear. Our highly trained specialists are available 24/7 via phone and on weekdays can assist through Uterine corpus cancer is the most prevalent gynecologic malignancy in the United States. In 2023 alone, over 66,000 new cases were expected, and over 13,000 deaths were due to this cancer.[1] Endometrial carcinomas accounted for a significant number of these cases, as fewer than 10% of uterine corpus cancers are sarcomas; this type of carcinoma comprises more than 83% of the uterine corpus Diseases addressed by the guidelines include AEH, endometrial cancer, uterine carcinosarcoma, uterine sarcoma, and trophoblastic tumor, and recurrence of these diseases. 4. Notes on using these guidelines. 1) There are fewer randomized controlled trials of treatment of uterine body tumor compared to lung, breast, and colorectal cancers. |ljt| psz| rzk| fdn| kfq| nkp| gbs| irr| irw| juj| bnm| sfg| kwx| fpf| mzh| qfn| muo| pwp| xwl| jor| qsk| asm| noj| sxq| eid| fsu| qwh| bdf| yec| zaw| glc| cyz| wuh| lrr| xki| ary| bwi| fim| kye| ggo| jcv| ikx| yzf| jmu| rzl| bec| qwk| pwl| fgz| rij|